• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺功能与甲状腺功能正常的中国老年人群中非酒精性脂肪性肝病的相关性。

Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese.

机构信息

Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Clin Endocrinol (Oxf). 2011 Aug;75(2):240-6. doi: 10.1111/j.1365-2265.2011.04016.x.

DOI:10.1111/j.1365-2265.2011.04016.x
PMID:21521285
Abstract

OBJECTIVE

Thyroid dysfunction commonly occurs in the elderly population and overt thyroid dysfunction is associated with some liver abnormalities. This study aimed to investigate the association of thyroid function with nonalcoholic fatty liver disease (NAFLD) in euthyroid elderly Chinese.

METHODS

A cross-sectional study was performed among 878 euthyroid elderly Chinese who took their annual healthy examination at Zhenhai Lianhua Hospital, Ningbo, China.

RESULTS

A total of 227 (25·85%) subjects fulfilled the diagnostic criteria of NAFLD. Patients with NAFLD had significantly lower levels of serum-free thyroxine (FT4) than controls (11·12 ± 1·43 vs 11·58 ± 1·47 pmol/l; P < 0·001). The prevalence rate of NAFLD decreased along with progressively higher serum FT4 levels (P for trend < 0·001). Age, gender and smoking status-adjusted correlation analysis showed that serum FT4 level was negatively correlated with body mass index, waist circumference, triglyceride and serum uric acid levels (All with P < 0·05). Stepwise logistic regression analysis showed that serum FT4 level was significantly associated with the risk for NAFLD [odds ratio (OR): 0·847, 95% confidence interval (CI): 0·743 - 0·966; P = 0·013].

CONCLUSION

Our findings suggest that thyroid function, even within the reference range, is associated with NAFLD in elderly Chinese.

摘要

目的

甲状腺功能障碍在老年人群中很常见,显性甲状腺功能障碍与一些肝脏异常有关。本研究旨在探讨甲状腺功能与中国老年甲状腺功能正常人群中非酒精性脂肪性肝病(NAFLD)的关系。

方法

对在中国宁波镇海莲华医院进行年度健康检查的 878 例甲状腺功能正常的老年中国人进行了横断面研究。

结果

共有 227 例(25.85%)患者符合 NAFLD 的诊断标准。与对照组相比,NAFLD 患者的血清游离甲状腺素(FT4)水平显著降低(11.12±1.43 比 11.58±1.47 pmol/L;P<0.001)。随着血清 FT4 水平的逐渐升高,NAFLD 的患病率呈下降趋势(P 趋势<0.001)。经年龄、性别和吸烟状况校正的相关分析显示,血清 FT4 水平与体重指数、腰围、甘油三酯和血尿酸水平呈负相关(均 P<0.05)。逐步逻辑回归分析显示,血清 FT4 水平与 NAFLD 的发病风险显著相关(比值比:0.847,95%置信区间:0.743-0.966;P=0.013)。

结论

我们的研究结果表明,即使在参考范围内,甲状腺功能也与中国老年人群中的 NAFLD 有关。

相似文献

1
Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese.甲状腺功能与甲状腺功能正常的中国老年人群中非酒精性脂肪性肝病的相关性。
Clin Endocrinol (Oxf). 2011 Aug;75(2):240-6. doi: 10.1111/j.1365-2265.2011.04016.x.
2
Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects.甲状腺功能与甲状腺功能正常受试者的非酒精性脂肪性肝病相关。
Endocr Res. 2015;40(2):74-8. doi: 10.3109/07435800.2014.952014. Epub 2014 Oct 20.
3
Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.甲状腺功能正常者中,游离三碘甲状腺原氨酸水平升高与非酒精性脂肪性肝病相关:生命线队列研究
Metabolism. 2017 Feb;67:62-71. doi: 10.1016/j.metabol.2016.11.002. Epub 2016 Nov 6.
4
Serum level of free thyroxine is an independent risk factor for non-alcoholic fatty liver disease in euthyroid people.血清游离甲状腺素水平是甲状腺功能正常人群非酒精性脂肪性肝病的独立危险因素。
Ann Palliat Med. 2022 Feb;11(2):655-662. doi: 10.21037/apm-21-3890.
5
Thyroid Function and Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects.甲状腺功能与甲状腺功能正常人群中非酒精性脂肪性肝病的风险。
Ann Hepatol. 2018 Aug 24;17(5):779-788. doi: 10.5604/01.3001.0012.3136.
6
Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population.内脏脂肪指数对甲状腺素游离三碘甲状腺原氨酸与游离甲状腺素比值及甲状腺功能正常人群非酒精性脂肪性肝病的中介效应分析。
Front Endocrinol (Lausanne). 2022 Aug 29;13:961803. doi: 10.3389/fendo.2022.961803. eCollection 2022.
7
Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population.糖化血红蛋白与老年中国人非酒精性脂肪性肝病的独立相关性。
BMC Gastroenterol. 2013 Jan 7;13:3. doi: 10.1186/1471-230X-13-3.
8
Free triiodothyronine levels are positively associated with non-alcoholic fatty liver disease in euthyroid middle-aged subjects.在甲状腺功能正常的中年受试者中,游离三碘甲状腺原氨酸水平与非酒精性脂肪性肝病呈正相关。
Endocr Res. 2015;40(4):188-93. doi: 10.3109/07435800.2014.987399. Epub 2014 Dec 22.
9
Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.非肥胖绝经后女性血清尿酸水平与肝脂肪变性的关系。
Climacteric. 2014 Dec;17(6):692-9. doi: 10.3109/13697137.2014.926323. Epub 2014 Aug 7.
10
FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism.FT3/FT4比值可独立于甲状腺功能正常和甲状腺功能减退患者的代谢参数预测非酒精性脂肪性肝病。
Clinics (Sao Paulo). 2016 Apr;71(4):221-5. doi: 10.6061/clinics/2016(04)08.

引用本文的文献

1
Evidence on the link between hypothyroidism and non-alcoholic fatty liver disease: an updated systematic review.甲状腺功能减退与非酒精性脂肪性肝病之间关联的证据:一项更新的系统评价。
BMC Endocr Disord. 2025 Jul 1;25(1):154. doi: 10.1186/s12902-025-01977-2.
2
Correlation Between Thyroid Hormone and Controlled Attenuation Parameters: A Cross-Sectional Population-Based Study.甲状腺激素与受控衰减参数之间的相关性:一项基于人群的横断面研究。
Diabetes Metab Syndr Obes. 2024 Dec 15;17:4777-4787. doi: 10.2147/DMSO.S490347. eCollection 2024.
3
Use of transient elastography for hepatic steatosis and fibrosis evaluation in patients with subclinical hypothyroidism.
应用瞬时弹性成像技术评估亚临床甲状腺功能减退症患者的肝脂肪变和纤维化。
Arch Endocrinol Metab. 2024 Aug 9;68:e230477. doi: 10.20945/2359-4292-2023-0477. eCollection 2024.
4
Baseline and change in serum lipid and uric acid level over time and incident of nonalcoholic fatty liver disease (NAFLD) in Chinese adults.中国成年人血清脂质和尿酸水平随时间的变化及其与非酒精性脂肪肝(NAFLD)发病的关系。
Sci Rep. 2024 Aug 9;14(1):18547. doi: 10.1038/s41598-024-69411-6.
5
Association between thyroid function and nonalcoholic fatty liver disease: a dose-response meta-analysis.甲状腺功能与非酒精性脂肪性肝病的关系:一项剂量-反应荟萃分析。
Front Endocrinol (Lausanne). 2024 Jun 25;15:1399517. doi: 10.3389/fendo.2024.1399517. eCollection 2024.
6
Relationship between thyroid hormone levels and metabolic dysfunction associated steatotic liver disease in patients with type 2 diabetes: A clinical study.甲状腺激素水平与 2 型糖尿病患者代谢功能障碍相关脂肪性肝病的关系:一项临床研究。
Medicine (Baltimore). 2024 Jun 28;103(26):e38643. doi: 10.1097/MD.0000000000038643.
7
Co-Morbid Hypothyroidism and Liver Dysfunction: A Review.合并甲状腺功能减退症与肝功能障碍:综述
Clin Med Insights Endocrinol Diabetes. 2024 Feb 11;17:11795514241231533. doi: 10.1177/11795514241231533. eCollection 2024.
8
Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study.甲状腺功能正常者甲状腺激素敏感性与代谢功能障碍相关脂肪性肝病的关系:一项横断面研究
Diabetes Metab Syndr Obes. 2023 Jul 19;16:2153-2163. doi: 10.2147/DMSO.S420872. eCollection 2023.
9
Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.瑞美替隆:一种口服的小分子、肝脏靶向、β 选择性甲状腺激素受体激动剂,用于治疗非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
touchREV Endocrinol. 2023 May;19(1):60-70. doi: 10.17925/EE.2023.19.1.60. Epub 2023 May 1.
10
Non-alcoholic Fatty Liver Disease in Overt Hypothyroidism: A Cross-Sectional Study in a Tertiary Care Hospital.显性甲状腺功能减退症中的非酒精性脂肪性肝病:一项三级医院的横断面研究。
Cureus. 2023 Apr 4;15(4):e37094. doi: 10.7759/cureus.37094. eCollection 2023 Apr.